Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Market Cap	10.48B
Revenue (ttm)	2.82B
Net Income (ttm)	315.29M
Shares Out	7.20M
EPS (ttm)	43.79
PE Ratio	33.25
Forward PE	33.70
Dividend	28.00 (1.87%)
Ex-Dividend Date	Jun 20, 2025

Volume	99
Average Volume	931
Open	1,500.00
Previous Close	1,550.00
Day's Range	1,500.00 - 1,545.00
52-Week Range	881.00 - 1,624.00
Beta	-0.10
RSI	53.37
Earnings Date	Jul 31, 2025

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco. It offers products in various therapeutic areas, including allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and other generic drugs. The company also provides its products in various forms, such as tablets, capsules, pouches, syrup...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 1,316
• Stock Exchange: Casablanca Stock Exchange
• Ticker Symbol: SOT

Financial Performance

In 2024, CBSE:SOT's revenue was 2.82 billion, an increase of 13.27% compared to the previous year's 2.49 billion. Earnings were 315.29 million, an increase of 19.99%.